ANGLE plc (AGL) - Total Assets

Latest as of June 2025: GBX18.08 Million GBX ≈ $2.20K USD

Based on the latest financial reports, ANGLE plc (AGL) holds total assets worth GBX18.08 Million GBX (≈ $2.20K USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See AGL book value for net asset value and shareholders' equity analysis.

ANGLE plc - Total Assets Trend (2001–2024)

This chart illustrates how ANGLE plc's total assets have evolved over time, based on quarterly financial data.

ANGLE plc - Asset Composition Analysis

Current Asset Composition (December 2024)

ANGLE plc's total assets of GBX18.08 Million consist of 64.5% current assets and 35.6% non-current assets.

Asset Category Amount (GBX) % of Total Assets
Cash & Equivalents GBX0.00 41.0%
Accounts Receivable GBX1.80 Million 7.1%
Inventory GBX1.58 Million 6.2%
Property, Plant & Equipment GBX0.00 0.0%
Intangible Assets GBX441.00K 1.7%
Goodwill GBX2.21 Million 8.7%

Asset Composition Trend (2001–2024)

This chart illustrates how ANGLE plc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see ANGLE plc market capitalisation.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: ANGLE plc's current assets represent 64.5% of total assets in 2024, a decrease from 94.9% in 2001.
  • Cash Position: Cash and equivalents constituted 41.0% of total assets in 2024, down from 60.1% in 2001.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 9.0% of total assets, an increase from 0.0% in 2001.
  • Asset Diversification: The largest asset category is goodwill at 8.7% of total assets.

ANGLE plc Competitors by Total Assets

Key competitors of ANGLE plc based on total assets are shown below.

Company Country Total Assets
Sonic Healthcare Ltd
AU:SHL
Australia AU$17.03 Billion
Eurofins-Cerep SA
PA:ALECR
France €84.58 Million
Inoviq Ltd
AU:IIQ
Australia AU$24.52 Million
Bcal Diagnostics Ltd
AU:BDX
Australia AU$7.17 Million
Imagion Biosystems Ltd
AU:IBX
Australia AU$932.48K
Integral Diagnostics Ltd
AU:IDX
Australia AU$1.43 Billion
Australian Clinical Labs Ltd
AU:ACL
Australia AU$562.50 Million
Monash Ivf Group Ltd
AU:MVF
Australia AU$510.21 Million

ANGLE plc - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 3.13 5.19 8.72
Quick Ratio 2.63 4.80 8.52
Cash Ratio 0.00 0.00 0.00
Working Capital GBX6.72 Million GBX19.07 Million GBX29.15 Million

ANGLE plc - Advanced Valuation Insights

This section examines the relationship between ANGLE plc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 0.47
Latest Market Cap to Assets Ratio 0.00
Asset Growth Rate (YoY) -18.4%
Total Assets GBX25.46 Million
Market Capitalization $94.18K USD

Valuation Analysis

Below Book Valuation: The market values ANGLE plc's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: ANGLE plc's assets decreased by 18.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for ANGLE plc (2001–2024)

The table below shows the annual total assets of ANGLE plc from 2001 to 2024.

Year Total Assets Change
2024-12-31 GBX25.46 Million
≈ $3.10K
-18.36%
2023-12-31 GBX31.18 Million
≈ $3.79K
-37.47%
2022-12-31 GBX49.87 Million
≈ $6.07K
+5.40%
2021-12-31 GBX47.31 Million
≈ $5.76K
+21.17%
2020-12-31 GBX39.05 Million
≈ $4.75K
+27.72%
2019-12-31 GBX30.57 Million
≈ $3.72K
+32.82%
2019-04-30 GBX23.02 Million
≈ $2.80K
+25.92%
2018-04-30 GBX18.28 Million
≈ $2.22K
+67.45%
2017-04-30 GBX10.92 Million
≈ $1.33K
+62.01%
2016-04-30 GBX6.74 Million
≈ $819.94
-39.94%
2015-04-30 GBX11.22 Million
≈ $1.37K
+82.14%
2014-04-30 GBX6.16 Million
≈ $749.49
-18.12%
2013-04-30 GBX7.52 Million
≈ $915.31
+45.09%
2012-04-30 GBX5.18 Million
≈ $630.86
-1.31%
2011-04-30 GBX5.25 Million
≈ $639.26
-2.76%
2010-04-30 GBX5.40 Million
≈ $657.39
-0.86%
2009-04-30 GBX5.45 Million
≈ $663.11
-40.63%
2008-04-30 GBX9.18 Million
≈ $1.12K
+18.57%
2007-04-30 GBX7.74 Million
≈ $941.98
-51.97%
2006-04-30 GBX16.12 Million
≈ $1.96K
0.00%
2005-04-30 GBX16.12 Million
≈ $1.96K
+33.68%
2004-04-30 GBX12.06 Million
≈ $1.47K
+1049.57%
2003-04-30 GBX1.05 Million
≈ $127.63
-18.56%
2002-04-30 GBX1.29 Million
≈ $156.71
-22.32%
2001-04-30 GBX1.66 Million
≈ $201.73
--

About ANGLE plc

LSE:AGL UK Diagnostics & Research
Market Cap
$94.18K
GBX774.07 Million GBX
Market Cap Rank
#30999 Global
#1120 in UK
Share Price
GBX2.40
Change (1 day)
-9.43%
52-Week Range
GBX1.75 - GBX10.50
All Time High
GBX156.00
About

ANGLE plc, a medical diagnostic company, develops cancer diagnostics products in the United Kingdom, Europe, North America, and internationally. The company develops Parsortix PC1 systems, a medical device for the capture and harvest of intact circulating tumour cells (CTCs) from metastatic breast cancer patient blood for subsequent user-validated downstream analysis. It also provides Portrait+ C… Read more